MetaphysicalCells

MetaphysicalCells

Share this post

MetaphysicalCells
MetaphysicalCells
AstraZeneca and AI Drug Discovery

AstraZeneca and AI Drug Discovery

“The potential benefits of artificial intelligence are huge, so are the dangers.” - Dave Waters

Marina T Alamanou's avatar
Marina T Alamanou
Dec 22, 2022
∙ Paid
1

Share this post

MetaphysicalCells
MetaphysicalCells
AstraZeneca and AI Drug Discovery
Share

News 📰: AstraZeneca a leading adopter of AI Drug Discovery

Earlier this year it was announced that the project of collaboratively trained AI between the MELLODDY platform (namely AstraZeneca, Amgen, Astellas, Bayer, Boehringer Ingelheim, GSK, Janssen, Merck, Novartis and Servier) outperformed single-partner models on multiple axes. In particular, Owkin’…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Marina T Alamanou
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share